Skip to main content
Contact
Site Search
Home
About
Who We Are
Leadership
Our Legacy
Science
Overview
Publications
Pipeline
Overview
Clinical Trials
Patients
Therapeutic Focus
Patient Resources
Access Policy
News/Events
Overview
Press Releases
Events & Presentations
Email and News Alerts
Careers
Overview
Our Values
Inside Momenta
Benefits
Search Openings
Home
About
Who We Are
Leadership
Our Legacy
Science
Overview
Publications
Pipeline
Overview
Clinical Trials
Patients
Therapeutic Focus
Patient Resources
Access Policy
News/Events
Overview
Press Releases
Events & Presentations
Email and News Alerts
Careers
Overview
Our Values
Inside Momenta
Benefits
Search Openings
Press Releases
Home
>
News/Events
>
Press Releases
Normal
Press Release RSS Feed (opens in new window)
Press release year list
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
12/11/2018
Momenta Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriter’s Option to Purchase Additional Shares
Download
PDF format download (opens in new window)
12/06/2018
UPDATE: Momenta Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Download
PDF format download (opens in new window)
12/05/2018
Momenta Pharmaceuticals Announces Proposed Public Offering of Common Stock
Download
PDF format download (opens in new window)
12/03/2018
Momenta Pharmaceuticals Provides Update on US Regulatory Strategy for M923, Proposed Biosimilar to HUMIRA®
Download
PDF format download (opens in new window)
11/07/2018
Momenta Pharmaceuticals Announces Publication of Phase 1 Study Data for Anti-FcRn Antibody, M281
Download
PDF format download (opens in new window)
11/07/2018
Momenta Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Corporate Update
Download
PDF format download (opens in new window)
11/06/2018
Momenta Pharmaceuticals Announces Global Settlement with AbbVie to Enable Commercialization of M923, a Proposed Biosimilar to HUMIRA® (adalimumab)
Download
PDF format download (opens in new window)
11/06/2018
Momenta Pharmaceuticals to Webcast Presentation at the Stifel 2018 Healthcare Conference
Download
PDF format download (opens in new window)
10/31/2018
Momenta Pharmaceuticals Announces Date of Third Quarter 2018 Financial Results Conference Call and Webcast
Download
PDF format download (opens in new window)
10/04/2018
Momenta Pharmaceuticals to Host R&D Day on October 11, 2018
Download
PDF format download (opens in new window)
10/01/2018
Momenta Pharmaceuticals Completes Strategic Review to Refocus its Operations and Drive Shareholder Value
Download
PDF format download (opens in new window)
08/09/2018
Momenta Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Corporate Update
Download
PDF format download (opens in new window)
08/02/2018
Momenta Pharmaceuticals Announces Date of Second Quarter 2018 Financial Results Conference Call and Webcast
Download
PDF format download (opens in new window)
06/06/2018
Momenta Pharmaceuticals to Webcast Presentation at the Goldman Sachs 39th Annual Global Healthcare Conference
Download
PDF format download (opens in new window)
05/17/2018
Momenta Pharmaceuticals Announces Presentation on M281, an Anti-FcRn Monoclonal Antibody, at 11th International Congress on Autoimmunity
Download
PDF format download (opens in new window)
05/10/2018
Momenta Pharmaceuticals to Webcast Presentation at the Bank of America Merrill Lynch Health Care Conference 2018
Download
PDF format download (opens in new window)
05/08/2018
Momenta Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Corporate Update
Download
PDF format download (opens in new window)
05/01/2018
Momenta Pharmaceuticals Announces Date of First Quarter 2018 Financial Results Conference Call and Webcast
Download
PDF format download (opens in new window)
03/05/2018
Momenta Pharmaceuticals to Webcast Presentation at Two Upcoming Investor Conferences
Download
PDF format download (opens in new window)
02/21/2018
Momenta Pharmaceuticals Reports Fourth Quarter and Year End 2017 Financial Results and Provides Corporate Update
Download
PDF format download (opens in new window)
02/13/2018
Momenta Pharmaceuticals Announces FDA Approval and Launch of Glatopa® (glatiramer acetate injection) 40 mg/mL
Download
PDF format download (opens in new window)
02/08/2018
Momenta Pharmaceuticals to Webcast Presentation at the LEERINK Partners 7th Annual Global Healthcare Conference
Download
PDF format download (opens in new window)
02/07/2018
Momenta Pharmaceuticals Announces Date of Fourth Quarter and Year End 2017 Financial Results Conference Call and Webcast
Download
PDF format download (opens in new window)
01/30/2018
Momenta Pharmaceuticals Announces Positive Outcome for Contracted Glatopa® (glatiramer acetate injection) Fill/Finish Manufacturer
Download
PDF format download (opens in new window)
01/05/2018
Momenta Pharmaceuticals Reports Positive Top-Line Phase 1 Data Showing Proof of Mechanism for M281, an Anti-FcRn Monoclonal Antibody, in Healthy Volunteers
Download
PDF format download (opens in new window)
01/03/2018
Momenta and Mylan Announce Development Strategy for M710, a Proposed Biosimilar to EYLEA® (aflibercept)
Download
PDF format download (opens in new window)